--- title: Matregenix Awarded $2M NIH Phase II SBIR Grant to Advance MatriNova Platform for Bone Regeneration description: Matregenix receives $2M NIH Phase II SBIR grant to advance its MatriNova platform for guided bone regeneration, in collaboration with the University of Michigan. image: https://storage.googleapis.com/mmstudio-images/gallery/unLXE6iDuoQ42DmZamjbTtM0ArJ2/1754963315186-0.jpg --- [![logo-new-2](https://www.matregenix.com/hubfs/Theme_2023/images/logo-new-2.svg "logo-new-2")](https://matregenix.com) - [Home](https://www.matregenix.com/nanofiber-solutions) - [About Us](https://www.matregenix.com/about-us) - [Technology](https://www.matregenix.com/nanofiber-technology) - [Contract Development](https://www.matregenix.com/contract-design-and-development) - Products - [Biomedical](https://www.matregenix.com/biomedical-technology) - [Filtration](https://www.matregenix.com/filtration-technology) - [Machinery](https://www.matregenix.com/nanofiber-electrospinning) - More - [Quality Assurance](https://www.matregenix.com/nanofiber-quality-assurance) - [Blog](https://www.matregenix.com/blog) - [News](https://www.matregenix.com/news) - [Career](https://www.matregenix.com/career) - [Request Quote](https://www.matregenix.com/request-quote) - [Financing Options](https://www.matregenix.com/nanofiber-electrospinning-machine-financing) - [Financial Conflict of Interest (FCOI) Policy](https://www.matregenix.com/financial-conflict-of-interest-fcoi-policy) - [EPM](https://www.matregenix.com/epm) - [Distributor](https://www.matregenix.com/distributors) - [Contact Us](https://www.matregenix.com/contact-us) # Matregenix Awarded $2M NIH Phase II SBIR Grant to Advance MatriNova Platform for Bone Regeneration Phase II award from NIH’s National Institute of Dental & Craniofacial Research will drive development of MatriNova™, an amino acid-based nanofiber membrane for guided bone regeneration (GBR), in collaboration with University of Michigan; marks Matregenix’s ninth SBIR/STTR grant to date. Mission Viejo, California, United States, August 13, 2025 -- Matregenix Inc., a California-based nanofiber technology company, today announced it has been awarded a **$2.039 million** Small Business Innovation Research (**SBIR**) Phase II grant by the **National Institute of Dental and Craniofacial Research (NIDCR)**, part of the National Institutes of Health (NIH). This prestigious grant will support the advancement of Matregenix’s proprietary advanced tissue repair platform – specifically **MatriNova™**, an innovative amino acid-based membrane – for use in **guided bone regeneration (GBR)** procedures. The project will be carried out in collaboration with the University of Michigan School of Dentistry’s research group led by Professor Marco Bottino, building on an ongoing partnership established in 2021. “This adds to the tremendous success of Matregenix securing highly competitive SBIR awards and speaks volumes about our technology,” said **Dr. Sherif Soliman, CEO of Matregenix**. To date, Matregenix has secured **nine SBIR/STTR grants** from various U.S. federal agencies, underscoring the credibility and innovative potential of its nanofiber platform. These awards – spanning support from the NIH as well as the Department of Defense – highlight broad confidence in Matregenix’s solutions to unmet needs in healthcare R&D. The company’s growth momentum is further evidenced by its recent expansion into a new **state-of-the-art 18,000 sq. ft. manufacturing facility in Mission Viejo, California**. This upgraded facility significantly enhances Matregenix’s capacity for scalable nanofiber production, positioning the company to meet increasing demand and accelerate the transition of its advanced biomaterials from the lab to the marketplace. With a strong track record of federal funding and new production capabilities, Matregenix is poised to continue driving innovation in tissue repair. The NIH Phase II grant will enable the company to refine and validate its MatriNova GBR membrane, bringing it closer to benefiting patients who need improved options for bone healing in dental and craniofacial procedures. ![](https://storage.googleapis.com/mmstudio-images/gallery/unLXE6iDuoQ42DmZamjbTtM0ArJ2/1754963315186-0.jpg) About Matregenix **Matregenix Inc.** is a California-based technology company that designs, develops, and manufactures highly tunable nanofibrous materials adaptable to customized needs in a wide range of applications. The company is at the forefront of nanofiber innovation, particularly in biomedical and filtration sectors, offering comprehensive product development and manufacturing services. ###### Share This Story, Choose Your Platform! - - [Matregenix Wins First Place at the Health Security Innovation Challenge](https://www.matregenix.com/news/matregenix-wins-first-place-at-the-health-security-innovation-challenge) [![logo-new 1](https://www.matregenix.com/hubfs/Theme_2023/images/logo-new%201.svg "logo-new 1")](https://matregenix.com/) - [Home](https://www.matregenix.com/nanofiber-solutions) - [About Us](https://www.matregenix.com/about-us) - [Technology](https://www.matregenix.com/nanofiber-technology) - [Biomedical](https://www.matregenix.com/biomedical-technology) - [Filtration](https://www.matregenix.com/filtration-technology) - [Machinery](https://www.matregenix.com/nanofiber-electrospinning) - [Contract Development](https://www.matregenix.com/contract-design-and-development) - [News](https://www.matregenix.com/news) - [Blog](https://www.matregenix.com/blog) **Contact us: [(617) 763-6334](tel:%20(617)%20763-6334)** [Privacy Policy](https://www.matregenix.com/privacy-policy) Copyright © 2026 - Matregenix. All rights reserved. ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Marketing team", "url" : "https://www.matregenix.com/news/author/marketing-team" }, "dateModified" : "2025-09-18T06:35:38.452Z", "datePublished" : "2025-09-18T06:34:09.000Z", "headline" : "Matregenix Awarded $2M NIH Phase II SBIR Grant to Advance MatriNova Platform for Bone Regeneration", "image" : [ "https://storage.googleapis.com/mmstudio-images/gallery/unLXE6iDuoQ42DmZamjbTtM0ArJ2/1754963315186-0.jpg" ], "mainEntityOfPage" : { "@id" : "https://www.matregenix.com/news/matregenix-awarded-2m-nih-phase-ii-sbir-grant-to-advance-matrinova-platform-for-bone-regeneration", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://www.matregenix.com/hubfs/Logo-01-Mar-06-2023-11-46-36-7770-PM.png" }, "name" : "Matregenix" } } ``` ```json { "@context" : "https://schema.org", "@id" : "https://www.matregenix.com/#organization", "@type" : "Organization", "address" : { "@type" : "PostalAddress", "addressCountry" : "US", "addressLocality" : "Mission Viejo", "addressRegion" : "CA", "postalCode" : "92691", "streetAddress" : "26021 Pala, Suite A" }, "brand" : [ { "@type" : "Brand", "name" : "Matregenix" }, { "@type" : "Brand", "name" : "ElectrospinTek", "url" : "https://www.electrospintek.com" } ], "description" : "Matregenix is a US-based nanofiber CDMO. We develop and manufacture electrospun nanofiber membranes for filtration and biomedical applications, from R&D to roll-to-roll production, and build electrospinning machines under the ElectrospinTek brand.", "email" : "info@matregenix.com", "founder" : { "@type" : "Person", "name" : "Sherif Soliman" }, "knowsAbout" : [ "electrospinning", "nanofiber membranes", "PFAS-free filter media", "nanofiber contract manufacturing", "tissue engineering scaffolds", "electrospinning machines" ], "legalName" : "Matregenix, Inc.", "logo" : "https://www.matregenix.com/hubfs/23649008/Theme_2023/images/logo-new-2.svg", "name" : "Matregenix", "sameAs" : [ "https://www.linkedin.com/company/matregenix", "https://www.electrospintek.com", "https://x.com/matregenix", "https://www.instagram.com/matregenix/", "https://www.facebook.com/matregenix/" ], "telephone" : "+1-617-763-6334", "url" : "https://www.matregenix.com" } ```